CYGB and liver cancer: There is evidence that Cygb can function as an intracellular anti-oxidant [37, 38, 55–57] including in hepatic stellate cells [57] and that Cygb deficiency has been linked to elevated liver cancer via a mechanism involving hepatosteatosis dependent on oxidative stress [58].